Literature DB >> 9743463

Vitravene--another piece in the mosaic.

S T Crooke.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9743463     DOI： 10.1089/oli.1.1998.8.vii

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN： 1087-2906


× No keyword cloud information.
  20 in total

1.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): synthesis and physicochemical studies.

Authors:  C J Wilds; M J Damha
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

3.  Quantitative assessment of chimeraplast stability in biological fluids by polyacrylamide gel electrophoresis and laser-assisted fluorescence analysis.

Authors:  David de Semir; Anna Avinyó; Sara Larriba; Virginia Nunes; Teresa Casals; Xavier Estivill; Josep M Aran
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

4.  PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures.

Authors:  Xueguang Lu; Ke Zhang
Journal:  Nano Res       Date:  2018-07-06       Impact factor: 8.897

5.  Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations.

Authors:  Eric W Alton; Homer A Boushey; Holger Garn; Francis H Green; Michael Hodges; Richard J Martin; Robert D Murdoch; Harald Renz; Stephen B Shrewsbury; Rosanne Seguin; Graham Johnson; Joel D Parry; Jeff Tepper; Paolo Renzi; Joy Cavagnaro; Nicolay Ferrari
Journal:  Nucleic Acid Ther       Date:  2012-07-18       Impact factor: 5.486

6.  Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration.

Authors:  H Wang; Q Cai; X Zeng; D Yu; S Agrawal; R Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 7.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

8.  Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.

Authors:  P Sazani; S H Kang; M A Maier; C Wei; J Dillman; J Summerton; M Manoharan; R Kole
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

9.  A one-step solid phase extraction method for bioanalysis of a phosphorothioate oligonucleotide and its 3' n-1 metabolite from rat plasma by uHPLC-MS/MS.

Authors:  Buyun Chen; Michael Bartlett
Journal:  AAPS J       Date:  2012-07-28       Impact factor: 4.009

10.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.